Bilibili Inc ADR (BILI) concluded trading on Thursday at a closing price of $17.13, with 6.82 million shares of worth about $116.86 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 6.33% during that period and on Thursday the price saw a loss of about -5.41%. Currently the company’s common shares owned by public are about 330.42M shares, out of which, 325.57M shares are available for trading.
Stock saw a price change of -10.73% in past 5 days and over the past one month there was a price change of -14.01%. Year-to-date (YTD), BILI shares are showing a performance of -5.41% which increased to 47.55% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $8.80 but also hit the highest price of $31.77 during that period. The average intraday trading volume for Bilibili Inc ADR shares is 7.24 million. The stock is currently trading -12.14% below its 20-day simple moving average (SMA20), while that difference is down -14.81% for SMA50 and it goes to 3.28% higher than SMA200.
Bilibili Inc ADR (NASDAQ: BILI) currently have 330.42M outstanding shares and institutions hold larger chunk of about 21.85% of that.
The stock has a current market capitalization of $5.58B and its 3Y-monthly beta is at 0.80. It has posted earnings per share of -$0.91 in the same period. It has Quick Ratio of 1.05 while making debt-to-equity ratio of 0.31. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BILI, volatility over the week remained 2.91% while standing at 3.34% over the month.
Stock’s fiscal year EPS is expected to rise by 97.62% while it is estimated to increase by 2351.27% in next year. EPS is likely to grow at an annualized rate of 4.73% for next 5-years, compared to annual growth of -46.30% made by the stock over the past 5-years.
On September 26, 2024, Goldman Upgrade their recommendations, while on September 25, 2024, Morgan Stanley Resumed their ratings for the stock with a price target of $20. Stock get an Overweight rating from Barclays on August 23, 2024.
